Clinical Trial Update: Efficacy and Safety of Butylphthalide for Acute Ischemic Stroke Patients Receiving Intravenous Thrombolysis or Endovascular Treatment [Phase 3]

View source ↗

Summary

Phase 3 trial assessing butylphthalide for acute ischemic stroke patients treated with IV thrombolysis or endovascular therapy completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Butylphthalide (butylphthalide)

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Acute Ischemic Stroke | Phase 3 | Status: COMPLETED